Abstract
Abstract A method for the detection of α-methyldopa in urine of individuals taking the drug at its therapeutic dose was developed. This test would be useful to ascertain patient compliance and to detect surreptitious use of the drug. The method is effective for detecting α-methyldopa in urine also known to contain azulfidine and/or other antihypertensive agents. No false positive or false negative analysis were obtained to date.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
